A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph plus acute lymphoblastic leukemia: Preliminary outcomes of a prospective study

被引：0
|
作者：
Tang, Hailong [1 ]
Jia, Weijing [1 ]
Jia, Shuangshuang [1 ]
Dong, Runan [2 ]
Gao, Shan [1 ]
Feng, Juan [1 ]
Dong, Hongjuan [1 ]
Gu, Hongtao [1 ]
Zhang, Tao [1 ]
Yuan, Ruifeng [1 ]
Liu, Xiangxiang [1 ]
Cheng, Lu [1 ]
Zhou, Shuya [2 ]
Gao, Guangxun [1 ]
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Hematol, Xian 710032, Peoples R China
[2] Weinan Cent Hosp, Dept Hematol, Weinan 714000, Shaanxi, Peoples R China
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 06期
关键词：
1ST-LINE THERAPY; SINGLE-CENTER; HYPER-CVAD; PONATINIB;
D O I：
10.1002/ajh.27289
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1177 / 1179
页数：3
相关论文
共 50 条
  • [1] Case report: Olverembatinib monotherapy: the chemotherapy-free regimen for an elderly patient with relapsed Ph-positive acute lymphoblastic leukemia
    Ding, Jianghua
    Li, Wen
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [2] An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
    Short, Nicholas J.
    Konopleva, Marina
    Kadia, Tapan
    Kebriaei, Partow
    Daver, Naval
    Huang, Xuelin
    Masarova, Lucia
    Cook, Robin
    Jain, Nitin
    Jabbour, Elias
    Kantarjian, Hagop
    Ravandi, Farhad
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : E229 - E232
  • [3] Combination of Olverembatinib and VP Regimen for Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Tan, Xu
    Chen, Guo
    Ma, Yingying
    Wang, Maihong
    Wen, Qin
    Liu, Hong
    Zhang, Xi
    Zhang, Cheng
    BLOOD, 2024, 144 : 1449 - 1449
  • [4] Chemotherapy-free regimen: a new hope in Philadelphia-positive acute lymphoblastic leukemia
    Saleh, Khalil
    Chahine, Claude
    Khalife, Nadine
    FUTURE ONCOLOGY, 2021, 17 (11) : 1265 - 1267
  • [5] Phase II study of combination of the hyperCVAD regimen with dasatinib in patients (pts) with newly diagnosed Philadelphia chromosome positive (Ph plus ) acute lymphoblastic leukemia (ALL)
    Ravandi, F.
    Faderl, S.
    Thomas, D. A.
    Brown, D.
    Garris, R.
    Borthakur, G.
    Ferrajoli, A.
    Cortes, J. E.
    Kantarjian, H. M.
    O'Brien, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] A Chemotherapy-Free Induction Followed by Allogeneic HSCT for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Leonard, Jessica T.
    Allen, Bryon
    Slater, Susan
    Maziarz, Richard T.
    Hayes-Lattin, Brandon
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S287 - S288
  • [7] Venetoclax in Combination with Pediatric-Inspired Chemotherapy in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I Trial
    Valtis, Yannis K.
    Geyer, Mark Blaine
    Torres, Martina
    Grogan, Mackenzie
    Shukla, Madhulika
    Stein, Eytan M.
    Park, Jae H.
    BLOOD, 2023, 142
  • [8] Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial
    Haddad, Fadi G.
    Jabbour, Elias
    Short, Nicholas J.
    Jain, Nitin
    Huang, Xuelin
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Daver, Naval
    Nasnas, Cedric
    Mayor, Ejiroghene
    Nasnas, Patrice Eric
    Deen, Wuliamatu
    Zoghbi, Marianne
    Thankachan, Jennifer
    Loiselle, Christopher
    Garris, Rebecca
    Ravandi, Farhad
    Kantarjian, Hagop M.
    BLOOD, 2023, 142
  • [9] A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL).
    Short, Nicholas James
    Kantarjian, Hagop M.
    Konopleva, Marina
    Bravo, Guillermo Montalban
    Ravandi, Farhad
    Jain, Nitin
    Kadia, Tapan M.
    Valero, Yesid Alvarado
    Chien, Kelly Sharon
    Daver, Naval Guastad
    Macaron, Walid
    Sasaki, Koji
    Thankachan, Jennifer
    Delumpa, Ricardo
    Mayor, Ejiroghene
    Deen, Wuliamatu
    Loiselle, Christopher
    Kwari, Monica
    Garris, Rebecca
    Jabbour, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study
    Gong, Xiaoyuan
    Fang, Qiuyun
    Gu, Runxia
    Qiu, Shaowei
    Liu, Kaiqi
    Lin, Dong
    Zhou, Chunlin
    Zhang, Guangji
    Gong, Benfa
    Liu, Yuntao
    Wei, Shuning
    Li, Yan
    Li, Shouyun
    Liu, Bingcheng
    Hu, Yimin
    Li, Junfan
    Wang, Ying
    Wei, Hui
    Mi, Yingchang
    Wang, Jianxiang
    BLOOD, 2023, 142
12345